Kenvue Trading Note Signals Neutral Short-Term Outlook Ahead of Kimberly-Clark Deal
Markets Daniel Marsh

Kenvue Trading Note Signals Neutral Short-Term Outlook Ahead of Kimberly-Clark Deal

Stock Traders Daily released a fresh trading note on Kenvue (KVUE) with neutral short-term signals and a weak long-term outlook, as traders await the Kimberly-Clark merger.

KVUE KMB
Ambev's Post-Earnings Rally Stalls; World Cup Hopes Tested Next Week
Earnings James Calloway

Ambev's Post-Earnings Rally Stalls; World Cup Hopes Tested Next Week

Ambev shares fell 0.51% on Friday, pausing after a strong Q1 earnings report. Investors now focus on the World Cup's potential to boost beer demand, with the stock up 13.2% YTD.

AMD Stock Retreats After Record Rally, Focus Shifts to AI Demand
Technology Sarah Chen

AMD Stock Retreats After Record Rally, Focus Shifts to AI Demand

AMD shares dropped 5.7% to $424.10, capping a 7.6% weekly decline after a record rally. Strong Q1 earnings and raised price targets failed to sustain momentum.

AMD NVDA AVGO INTC
QuantumScape Ends Volatile Week Lower; Focus on Eagle Line Progress
Technology Sarah Chen

QuantumScape Ends Volatile Week Lower; Focus on Eagle Line Progress

QuantumScape shares fell 6.9% Friday to $8.01 but still gained 6.6% for the week. The pre-revenue solid-state battery company reported a Q1 loss and highlighted Eagle Line production.

QS
Biogen Closes Apellis Takeover; CVR Offers Upside
Markets Daniel Marsh

Biogen Closes Apellis Takeover; CVR Offers Upside

Biogen completed its $41/share cash acquisition of Apellis, delisting the stock from Nasdaq. Shareholders also received a contingent value right that could pay up to $4 if Syfovre sales hit targets.

BIIB APLS
Vale Outperforms Slumping Brazil Market on Iron Ore Strength
Commodities Rebecca Torres

Vale Outperforms Slumping Brazil Market on Iron Ore Strength

Vale shares rose 0.76% in São Paulo on Friday, outperforming the falling Ibovespa, as iron ore prices held near 52-week highs and the company projected $1.5 billion in additional free cash flow from its iron ore unit in 2026.

RIO
Netflix's Ad Push Faces Market Test as Stock Holds Steady
Earnings James Calloway

Netflix's Ad Push Faces Market Test as Stock Holds Steady

Netflix shares closed at $87.02 Friday, up 0.09% but down 0.5% from last week. The company announced its ad-supported plan now reaches over 250 million global viewers, with expansion to 15 more countries by 2027.

NFLX GOOGL DIS
Palantir's Upbeat Forecast Fails to Lift Stock as AI Rally Stalls
Technology Sarah Chen

Palantir's Upbeat Forecast Fails to Lift Stock as AI Rally Stalls

Palantir closed at $133.99 on Friday, down 2.8% from May 8, despite raising its 2026 revenue outlook. The Nasdaq ended a six-week rally as oil and yields weighed on AI stocks.

PLTR MSFT NVDA
Bradesco Shares Slip as Credit Concerns Weigh on Brazil's Market
Markets Daniel Marsh

Bradesco Shares Slip as Credit Concerns Weigh on Brazil's Market

Bradesco preferred shares declined 4.84% over the past week to R$17.69, as rising credit costs and political uncertainty offset a 16.1% increase in first-quarter net income.

ServiceNow Gains Ahead of Key Week After Debt Sale and AI Focus
Technology Sarah Chen

ServiceNow Gains Ahead of Key Week After Debt Sale and AI Focus

ServiceNow shares rose 5.05% to $95.07, outperforming major indexes, after completing a $4 billion debt offering to fund its Armis acquisition.

NOW CRM MSFT
Coeur Mining Drops 9% as Dividend Date Approaches
Markets Daniel Marsh

Coeur Mining Drops 9% as Dividend Date Approaches

Coeur Mining shares dropped 9% on Friday to $17.61, with a dividend record date of May 22. Analyst downgrade and falling metals prices pressure the stock.

CDE GDX SLV
Pfizer Faces Investor Scrutiny After Weekly Decline Amid Pipeline Concerns
Earnings James Calloway

Pfizer Faces Investor Scrutiny After Weekly Decline Amid Pipeline Concerns

Pfizer shares dropped 1.63% on Friday to $25.33, lagging the S&P 500. Despite a 5% revenue increase and reaffirmed 2026 guidance, investor caution persists over pipeline risks and competitive pressure from Eli Lilly.

PFE LLY BMY NVDA WMT